HERON THERAPEUTICS, INC.

HERON THERAPEUTICS, INC. is a Corporation in WILMINGTON, United States with 1 ISIN-identified security mapped to its LEI, which is how regulators tie a traded instrument to the issuer behind it.

The LEI has been on record for 12 years, since 28 Jun 2014. That is about 5 years earlier than the median LEI in United States, which dates from 2019 — an early adopter by local standards.

Annual re-validation is 885 days overdue: it fell due 13 Jun 2024. An LEI that is not re-validated lapses, which does not invalidate it but marks the reference data as unverified.

This archive holds 2 versions of the record. The most recent change was on 29 Jul 2026 and altered the legal address; the oldest version we hold dates from 6 Jul 2026. GLEIF publishes only the current state, so superseded values are not available from the source.

The LEI is issued and maintained by Bloomberg Finance L.P., one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 1 ISIN is mapped to this entity in the GLEIF cross-reference files.

No direct accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is lapsed, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.